| Using active surveillance for Gleason 7 (3+ 4) prostate cancer: A narrative review R Bernardino, RK Sayyid, R Leão, AR Zlotta, T van der Kwast, L Klotz, ... Canadian Urological Association Journal 18 (4), 2024 | 3 | 2024 |
| Increasing trend of utilising active surveillance for Gleason Score 7 (3+ 4) prostate cancer R Bernardino, RK Sayyid, R Leão, AR Zlotta, T van der Kwast, L Klotz, ... BJU Int 132, 638-40, 2023 | 3 | 2023 |
| Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer RK Sayyid, R Bernardino, Z Al‐Daqqaq, R Tiwari, J Cockburn, ... BJU international 132 (6), 664-670, 2023 | 1 | 2023 |
| Epigenetic alterations in urothelial bladder cancer associated with disease outcomes FM Nunes, JD Apolónio, A Mota‐Pinto, R Leão International Journal of Urology, 2023 | 1 | 2023 |
| Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer RM Bernardino, RK Sayyid, K Lajkosz, Z Al-Daqqaq, JG Cockburn, ... European Urology Focus, 2023 | 4 | 2023 |
| Increasing Trends of Utilizing Active Surveillance for Gleason 7 (3+ 4) Prostate Cancer R Bernardino, RK Sayyid, R Leão, AR Zlotta, T van der Kwast, L Klotz, ... BJU international, 2023 | | 2023 |
| Testicular prostheses–impact on quality of life and sexual function AS Araújo, S Anacleto, R Rodrigues, C Tinoco, A Cardoso, C Oliveira, ... Asian Journal of Andrology, 10.4103, 2023 | 3 | 2023 |
| European Association of Urology Guidelines on Testicular Cancer: 2023 Update A Patrikidou, W Cazzaniga, D Berney, J Boormans, I de Angst, D Di Nardo, ... European Urology, 2023 | 59 | 2023 |
| A multicenter prospective validation study of the 3-cm cut-off in stage I seminoma (S3MI-PT). M Fontes-Sousa, H Magalhães, R Leão, A Mansinho, M Malheiro, ... Journal of Clinical Oncology 41 (6_suppl), TPS435-TPS435, 2023 | | 2023 |
| THOR is a targetable epigenetic biomarker with clinical implications in breast cancer JD Apolónio, JS Dias, MT Fernandes, M Komosa, T Lipman, CH Zhang, ... Clinical Epigenetics 14 (1), 1-22, 2022 | 10 | 2022 |
| Prevalence and Management of Incidental Testicular Masses—A Systematic Review D Henriques, A Mota Pinto, H Donato, R Leão Journal of Clinical Medicine 11 (19), 5770, 2022 | 6 | 2022 |
| Diagnostic and predictive biomarkers in testicular germ cell tumors J Lobo, R Leão Frontiers in Oncology 12, 1027363, 2022 | 3 | 2022 |
| Laparoscopic treatment of entero-neobladder fistula after radical cystectomy AS Araújo, S Anacleto, C Laranjo-Tinoco, A Cardoso, N Morais, JN Torres, ... Journal of Surgical Case Reports 2022 (9), rjac419, 2022 | | 2022 |
| Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up☆ J Oldenburg, DM Berney, C Bokemeyer, MA Climent, G Daugaard, ... Annals of Oncology 33 (4), 362-375, 2022 | 93 | 2022 |
| Patient-centered care can be improved by joint meetings between cancer patient group leaders and health care providers JO Herrera-Caceres, R Ajaj, R Leão, S Barello, F Rodriguez-Covarrubias, ... Patient education and counseling 105 (3), 786-787, 2022 | 1 | 2022 |
| Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer DD Lee, M Komosa, S Sudhaman, R Leão, CH Zhang, JD Apolonio, ... The Journal of Clinical Investigation 131 (21), 2021 | 14 | 2021 |
| Circulating MicroRNAs, the next-generation serum biomarkers in testicular germ cell tumours: a systematic review R Leao, M Albersen, LHJ Looijenga, T Tandstad, C Kollmannsberger, ... European urology 80 (4), 456-466, 2021 | 76 | 2021 |
| Joint cancer patient/clinician meetings shift views, inform health care providers and support collaboration to improve patient-centred care JO Herrera-Caceres, R Ajaj, R Leão, S Barello, F Rodriguez-Covarrubias, ... Patient Education and Counseling, 2021 | | 2021 |
| Utility of serum miR-371a-3p in predicting relapse on surveillance in patients with clinical stage I testicular germ cell cancer J Lobo, R Leao, AJM Gillis, A van den Berg, L Anson-Cartwright, ... European Urology Oncology 4 (3), 483-491, 2021 | 50 | 2021 |
| Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell … CD Fankhauser, J Oldenburg, P Albers, F Algaba, C Bokemeyer, ... European Urology 80 (1), 4-6, 2021 | 6 | 2021 |
Dr. Bruno Jorge PereiraInstituto Português de Oncologia de Coimbra在 fcsaude.ubi.pt 的电子邮件经过验证
